A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection
Hepatic Medicine: Evidence and Research · 2010
DOI: 10.2147/hmer.s11916 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Hepatic Medicine: Evidence and Research, 2010. Verfasst von Nan Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Peking University Health Science Center, Beijing, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Peking University Health Science Center, Beijing, China.
Zitieren
APA
Xiao, N., Shi, S., & Zhuang, H. (2010). A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection. Hepatic Medicine: Evidence and Research. https://doi.org/10.2147/hmer.s11916
Vancouver
Xiao N, Shi S, Zhuang H. A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection. Hepatic Medicine: Evidence and Research. 2010. doi:10.2147/hmer.s11916
BibTeX
@article{Xiao2010,
author = {Xiao, Nan and Shi, Shuang and Zhuang, Hui},
title = {A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection},
journal = {Hepatic Medicine: Evidence and Research},
year = {2010},
doi = {10.2147/hmer.s11916}
}
EUVIMED